These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11936121)

  • 1. Treatment of acute hepatitis C with interferon alfa-2b.
    Tocci G; Visco-Comandini U; Antonucci G
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936121
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acute hepatitis C with interferon alfa-2b.
    Seligman HK; Fox RK
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936120
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acute hepatitis C with interferon alfa-2b.
    Patel R; Germer JJ
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11932480
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute hepatitis C infection: an indication for alfa interferon therapy?
    van der Vlies CH; Tang TJ; Niesters HG; Zondervan PE; Janssen HL; de Man RA
    Neth J Med; 2000 Jul; 57(1):30-3. PubMed ID: 10863000
    [No Abstract]   [Full Text] [Related]  

  • 5. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
    Malnick SD; Basevitch A
    Gastroenterology; 2006 Aug; 131(2):683; author reply 683-4. PubMed ID: 16890628
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acute hepatitis C with interferon alfa-2b.
    Muir A; Rockey DC
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936122
    [No Abstract]   [Full Text] [Related]  

  • 7. Pegylated interferon alpha-2b in patients with acute hepatitis C.
    Mukhopadhyay A
    Natl Med J India; 2006; 19(4):201-2. PubMed ID: 17100108
    [No Abstract]   [Full Text] [Related]  

  • 8. Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference?
    Sierra F
    J Hepatol; 2007 Feb; 46(2):349; author reply 349-50. PubMed ID: 17161495
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of hepatitis C virus nonstructural region antigens and detection of their relative antibodies.
    Peng X; Wang Q
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):80-4. PubMed ID: 11503033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute hepatitis C in a child with thalassemia major using weight-based peginterferon alpha-2b.
    Sharara AI; Aoun E; Koussa S; Inati A; Taher A
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1221. PubMed ID: 16824084
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b.
    Venezia G; Licata A; Di Marco V; Craxì A; Almasio PL
    Dig Liver Dis; 2005 Nov; 37(11):882-5. PubMed ID: 16169301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
    Tassopoulos NC; Koutelou MG; Papatheodoridis G; Polychronaki H; Delladetsima I; Giannikakis T; Todoulos A; Toliopoulos A; Hatzakis A
    Gut; 1993; 34(2 Suppl):S130-2. PubMed ID: 7686113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
    Molloy PJ; Azzouz M; Van Thiel DH
    Am Fam Physician; 1996 Oct; 54(5):1598-605. PubMed ID: 8857782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute hepatitis C-how to explain the differences?
    Wedemeyer H; Cornberg M; Wiegand J; Jäckel E; Manns MP
    Gastroenterology; 2006 Aug; 131(2):682-3; author reply 683-4. PubMed ID: 16890627
    [No Abstract]   [Full Text] [Related]  

  • 16. Peginterferon alfa-2b treatment for patients affected by acute hepatitis C: presentation of six case reports.
    Scotto G; Palumbo E; Fazio V; Cibelli DC; Saracino A; Angarano G
    Infection; 2005 Feb; 33(1):30-2. PubMed ID: 15750757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute hepatitis C with interferon alfa-2b.
    Jaeckel E; Cornberg M; Wedemeyer H; Santantonio T; Mayer J; Zankel M; Pastore G; Dietrich M; Trautwein C; Manns MP;
    N Engl J Med; 2001 Nov; 345(20):1452-7. PubMed ID: 11794193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.
    Reichard O; Foberg U; Frydén A; Mattsson L; Norkrans G; Sönnerborg A; Wejstål R; Yun ZB; Weiland O
    Hepatology; 1994 Feb; 19(2):280-5. PubMed ID: 7507462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
    Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.